stockrowDr. Reddy's Laboratories Ltd
RDY Healthcare Drug Manufacturers Specialty & Generic
Dr. Reddy's Laboratories Ltd’s revenue for fiscal 2026 (year ended March 2026) was $3.6 billion, down 6.06% from fiscal 2025.
- Revenue
- −10.1%
- EPS
- −36.8%
- Free cash flow
- −70.5%
- Total debt
- +14.1%
Quarter to September 2026, against a year earlier
Follow RDY
Alert me
Dr. Reddy's Laboratories Ltd (RDY) Net income
Dr. Reddy's Laboratories Ltd's net income for fiscal 2026 was $452.0M, down 32.6% from $671.0M in fiscal 2025. Over the twelve months to 30 September 2026 it was $273.0M. Over the past ten years it has ranged from $151.0M (fiscal 2018) to $671.0M (fiscal 2025); the current reading is higher than 75% of that period. Dr. Reddy's Laboratories Ltd ranks 9th of 84 Drug Manufacturers Specialty & Generic companies by net income.
Net income, annual
Embed this chart
Annual newest first
| Period | Net income | Change |
|---|---|---|
| FY2026 | $452.0M | (32.64%) |
| FY2025 | $671.0M | 0.45% |
| FY2024 | $668.0M | 21.90% |
| FY2023 | $548.0M | 76.21% |
| FY2022 | $311.0M | 31.78% |
| FY2021 | $236.0M | (8.88%) |
| FY2020 | $259.0M | (4.78%) |
| FY2019 | $272.0M | 80.13% |
| FY2018 | $151.0M | (18.82%) |
| FY2017 | $186.0M | (38.41%) |
Quarterly newest first
| Period | Net income | Change |
|---|---|---|
| Sep 2026 | $94.0M | 104.35% |
| Jun 2026 | $46.0M | 1,050.00% |
| Mar 2026 | $4.0M | (96.90%) |
| Dec 2025 | $129.0M | (16.77%) |
| 43 more quarters | Free account |
Against its own ten years
Net income against peers
| Company | Net income |
|---|---|
| NBIX Neurocrine Biosciences, Inc. compare | $702.5M |
| RDY Dr. Reddy's Laboratories Ltd | $273.0M |
| LNTH Lantheus Holdings, Inc. compare | $269.9M |
| AMRX AMNEAL PHARMACEUTICALS, INC. compare | $209.5M |
| KNSA Kiniksa Pharmaceuticals International, plc compare | $109.6M |
| ALKS Alkermes plc compare | −$351.0K |
| HIMS Hims & Hers Health, Inc. compare | −$142.0M |
| ELAN Elanco Animal Health Incorporated compare | −$199.0M |
| VTRS Viatris Inc. compare | −$607.8M |
What Net income is
Net Income tells an investor how much profit a company kept in a period after every cost, interest charge and tax.
Reported line item
More on RDY
- Revenue
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement